Author

Lin Chang 1

1 David Geffen School of Medicine,Los Angeles,United States

A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL

Lin Chang

A NOVEL SCORE TO EVALUATE ABDOMINAL SYMPTOM IMPROVEMENT IN PATIENTS WITH CONSTIPATION-PREDOMINANT IBS DEMONSTRATES EFFICACY OF LINACLOTIDE FOR IMPROVING ABDOMINAL BLOATING, DISCOMFORT, AND PAIN IN A PHASE 3B TRIAL

Lin Chang, Brian Lacy, Baharak Moshiree, Amy Kassebaum, Jessica L. Abel, Jennifer Hanlon, Wilmin P Bartolini, Ramesh Boinpally, Wieslaw Bochenek, Susan Fox, Madhuja Mallick, Ken Tripp, Nick Omniewski, Elizabeth Shea, Niels Borgstein

A positive diagnostic strategy is preferred in IBS

Lin Chang

Biomarkers

Lin Chang

BITTER TASTE RECEPTOR T2R38 EXPRESSION IN THE COLON OF OVERWEIGHT/OBESE AND LEAN SUBJECTS

Rocco Latorre, Jennifer Huynh, Arpana Gupta, Maurizio Mazzoni, Paolo Clavenani, Lin Chang, Emeran A Mayer, Roberto De Giorgio, Catia Sternini

Constipation

Lin Chang

Constipation

Lin Chang

EFFICACY AND SAFETY OF OLORINAB, A PERIPHERALLY ACTING, HIGHLY SELECTIVE, FULL AGONIST OF CANNABINOID RECEPTOR 2, FOR THE TREATMENT OF ABDOMINAL PAIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: RESULTS FROM A PHASE 2B RANDOMIZED STUDY

Brooks D Cash, Anthony J. Lembo, David C. Kunkel, Brett A. English, Beatriz Lindstrom, Sharon Skare, Charlie Liu, Stewart Turner, Fabio Cataldi, Saleem Desai, Donald Lipkis, Jan Tack, Lin Chang

EFFICACY AND SAFETY OF OLORINAB, A PERIPHERALLY ACTING, HIGHLY SELECTIVE, FULL AGONIST OF CANNABINOID RECEPTOR 2, FOR THE TREATMENT OF ABDOMINAL PAIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: RESULTS FROM A PHASE 2B RANDOMIZED STUDY

Lin Chang

Extraintestinal symptoms in IBS

Lin Chang

Item 1 - 10 / 15
1
2